Cabaletta Bio CABA
NASDAQ CABA
$1.52 -0.02 (-1.30%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cabaletta Bio (CABA) Preferred Stock Liabilities (2018 - 2019)

Updated

Cabaletta Bio (CABA) posted Preferred Stock Liabilities of $97.95 million for Q3 2019, unchanged from the prior quarter.

Analysis

Cabaletta Bio (CABA) Preferred Stock Liabilities (2018 - 2019) Analysis & Trends

At the end of FY2018, Cabaletta Bio's Preferred Stock Liabilities came in at $43.92 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Cabaletta Bio 226.74 Mn 1.64 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2019 97.95 Mn
Jun 30, 2019 97.95 Mn
Dec 31, 2018 43.92 Mn
API Access

Cabaletta Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=CABA&period=max&api_key=YOUR_API_KEY